Page last updated: 2024-09-05

alanyl-glutamyl-aspartyl-glycine and fluorouracil

alanyl-glutamyl-aspartyl-glycine has been researched along with fluorouracil in 1 studies

Compound Research Comparison

Studies
(alanyl-glutamyl-aspartyl-glycine)
Trials
(alanyl-glutamyl-aspartyl-glycine)
Recent Studies (post-2010)
(alanyl-glutamyl-aspartyl-glycine)
Studies
(fluorouracil)
Trials
(fluorouracil)
Recent Studies (post-2010) (fluorouracil)
18182845,5629,30714,663

Protein Interaction Comparison

ProteinTaxonomyalanyl-glutamyl-aspartyl-glycine (IC50)fluorouracil (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.32
Thymidylate synthaseMus musculus (house mouse)1.58
AromataseHomo sapiens (human)0.63

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kosenko, IA; Vishnevskaia, EE1

Trials

1 trial(s) available for alanyl-glutamyl-aspartyl-glycine and fluorouracil

ArticleYear
[Long-term results of comprehensive treatment for cervical cancer with poor prognosis].
    Voprosy onkologii, 1999, Volume: 45, Issue:4

    Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Peptides; Survival Analysis; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms

1999